Relevance of intracranial hypertension control in the management of Cryptococcus neoformans meningitis related to AIDS

Infection

Volumn 41, Issue 6, 2013, Pages 1073-1077

  De Vedia, L ^a   Arechavala, A ^a   Calderon M I ^a   Maiolo, E ^a   Rodriguez A ^a   Lista, N ^a   Di Virgilio, E ^a   Cisneros, J C ^a   Prieto, R ^a  

^a HOSPITAL F J MUÑIZ   (Argentina)

Author keywords

AIDS; Cryptococcal meningitis; High intracranial pressure

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; FLUCONAZOLE; FUNGUS ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBIOTIC THERAPY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CEREBROSPINAL FLUID; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCUS NEOFORMANS; DISEASE CONTROL; FEMALE; HUMAN; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; FEMALE; HUMANS; INTRACRANIAL HYPERTENSION; MALE; MENINGITIS, CRYPTOCOCCAL; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84890364474     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-013-0538-4     Document Type: Article

References (22)

1. Mirza SA, Phelan M, Rimland D, et al. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis. 2003;36:789-94.
2. Negroni R, Helou SH, López Daneri G, Robles AM, Arechavala A, Bianchi MH. Interrupción exitosa de la profilaxis secundaria antifúngica en la criptococosis asociada al SIDA. Rev Argent Microbiol. 2004;36:113-7.
3. Dromer F, Mathoulin-Pelissier S, Launay O, et al. Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. PLoSMed. 2007;4:e21.
4. Kendi C, Penner J, Koech J, Nyonda M, Cohen CR, Bukussi EA et al. Predictors of outcome in routine care for Cryptococcal meningitis in Western Kenya: lessons for HIV outpatient care in resource-limited settings. Postgrad Med J. 2013;89:73-7.
5. Garbyll JR, Sobel J, Saag M, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. Clin Infect Dis. 2000;30:47-54.
6. Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2010;50:291-322.
7. Saag MS, Graybill JR, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis. 2000;30:710-8.
8. Shoham S, Cover C, Donegan N, Fulnecky E, Kumar P. Cryptococcus neoformans meningitis at 2 Hospitals in Washington, DC: adherence of health care providers to published practice guidelines for the management of cryptococcal disease. Clin Infect Dis. 2005;40:477-9.
9. Pappas PG. Managing cryptococcal meningitis is about handling the pressure. Clin Infect Dis. 2005;40:480-2.
10. Denning DW, Armstrong RW, Lewis BH, Stevens DA. Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome. Am J Med. 1991;91:267-72.
11. Vidal JE, Gerhardt J, Peixoto de Miranda EJ, Dauar RF, Oliveira Filho GS, Penalva de Oliveira AC, Boulware DR. Role of quantitative CSF microscopy to predict culture status and outcome in HIV-associated cryptococcal meningitis in a Brazilian cohort. Diagn Microbiol Infect Dis. 2012;73(1):68-73.
12. Kambugu AD, Meya DB, Rhein J, et al. Outcomes of cryptocccal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. Clin Infect Dis. 2008;46:1694-701.
13. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR 2009; 58:1-198.
14. Lortholary O, Poizat G, Zeller V, et al. Long-term outcome of AIDS associated cryptococcosis in the era of combination antiretroviral therapy. AIDS. 2006;20:2183-91.
15. Powderly WG. Current approach to the acute management of cryptococcal infections. J Infect. 2000;41:18-22.
16. van der Horst CM, Saag MS, Cloud GA, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med. 1997;337:15-21.
17. Negroni R (2008) Criptococosis. In: Benetucci J. Sida y enfermedades asociadas. Diagnóstico, clínica y tratamiento 3ra. Ed. FUNDAI, Buenos Aires 332-6.
18. Loyse A, Wainwright H, Jarvis J, Bicanic T, Rebe K, Meintjes G, Harrison T. Histopathology of the arachnoid granulations and brain in HIV-associated cryptococcal meningitis: correlation with cerebrospinal fluid pressure. AIDS. 2010;24:405-10.
19. Anekthananon T, Manosuthi W, Chetchotisakd P, et al. Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients. Int J STD AIDS. 2011;22(11):665-70.
20. Megson GM, Stevens DA, Hamilton JR, Denning DW. d-Mannitol in cerebrospinal fluid of patients with AIDS and cryptococcal meningitis. J Clin Microbiol. 1996;34:218-21.
21. Sun HY, Hung CC, Chang SC. Management of cryptococcal meningitis with extremely high intracranial pressure in HIV-infected patients. Clin Infect Dis. 2004;38:1790-2.
22. Bicanic T, Brouwer A, Meintjes G, et al. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures. AIDS. 2009;23:701-6.